This study is looking at how a device called the Bodyport Cardiac Scale can help predict problems caused by too much fluid in people with kidney disease who are on peritoneal dialysis (a type of treatment for kidney failure). The Bodyport Cardiac Scale measures different body signals to understand your fluid levels. The goal is to see if these measurements can tell us when fluid overload might lead to health issues. We are looking for people aged 21 or older who are receiving automated peritoneal dialysis and can stand on two bare feet without help. The study will measure how well the Bodyport Cardiac Scale predicts these events over one year. The current status of this study is unclear.

Study design

This is an observational study, meaning researchers will watch and collect information without giving a specific treatment. It plans to include 125 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will measure how well the Bodyport Cardiac Scale predicts events over one year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.